Funded Grants

The V Foundation’s grant making model ensures the most promising cancer research projects at state-of-the-art facilities around the country are funded. Cancer research grants are awarded to innovative researchers with the most cutting-edge ideas on how to improve cancer diagnosis methods, prevent cancer recurrences or defeat cancer. 100% of direct donations are used to fund projects we identify as the most likely to help those diagnosed with cancer.

2023
Christina Towers, PhD
Uncovering Novel Metabolic Susceptibilities in Pancreatic Cancer
Read More
2023
Ly Vu, PhD
Defining a high-resolution and functional map of m6A RNA epitranscriptome in normal...
Read More
2023
Sarah Adams, MD
VSTM5 as a novel treatment predictive biomarker for CTLA4 immune therapy in...
Read More
2023
Kelly Bolton, MD, PhD
Investigating the use of trilaciclib as a novel therapy to prevent clonal...
Read More
2023
Eva Hernando-Monge, PhD
Novel Metabolic Adaptions as Targets in Melanoma Brain Metastasis
Read More
2023
Juliana Hofstatter Azambuja, PhD
MALT1 as a therapeutic target in H3K27M-mutant Diffuse Midline Glioma
Read More
2023
Sarah Johnstone, MD, PhD
Architectural protein mutations rewire ovarian cancer genomes
Read More
2023
Katherine Tossas, PhD, MS
Elucidating the influence of the vaginal microbiome and stress-response pathways on racial...
Read More
2023
Christina Curtis, PhD
Characterizing and circumventing mechanisms of immunotherapy resistance in breast cancer
Read More
2023
Sana Karam, MD, PhD
Overcoming therapeutic resistance to radiation therapy in pancreatic cancer with STAT3 inhibition...
Read More
2023
Marina Konopleva, MD, PhD
Elucidating the role of BAX as a novel druggable driver of Venetoclax...
Read More
2023
Maayan Levy, PhD & Bryson Katona, MD PhD
Colorectal cancer interception in familial adenomatous polyposis through beta-hydroxybutyrate supplementation
Read More
2023
Roger Lo, MD, PhD
Blocking Genomic Instability to Prevent Acquired Resistance
Read More
2023
David Oh, MD, PhD
Therapeutic modulation of cytotoxic CD4+ T cells via KLRG1 to overcome primary...
Read More
2023
Jonathan Peled, MD, PhD
Overcoming therapeutic resistance in myeloma: microbiome metabolites to augment anti-tumor immunity
Read More
2023
David Schlaepfer, PhD
Overcoming Ovarian Cancer Immune Resistance
Read More